Third Time’s Not A Charm: Discovery’s Surfaxin Receives “Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Synthetic surfactant for prevention of respiratory distress syndrome in premature infants is deemed “approvable” by FDA.